Investor Relations

NYSE: CSLT
$3.15
(Common Stock)
Change (%): +0.00 (+0%)
Volume: 186,000
March 22, 2017
20 minute delay
Bryan Roberts, PhD

, Chairman of the Board and Co-Founder, Partner, Venrock

Bryan Roberts, Ph.D., joined Venrock as a Kauffman Fellow in 1997. He is based in Venrock’s Palo Alto office and focuses on a broad range of health care investments. Bryan is currently Chairman of the Board of Directors of Castlight Health, Achaogen, (NASDAQ: AKAO) and Ironwood Pharmaceuticals (NASDAQ: IRWD) and as a director of Zeltiq Aesthetics (NASDAQ: ZLTQ) and Vitae Pharmaceuticals (NASDAQ: VTAE) and also serves on the Boards of several other private companies, including Ikaria, Intarcia, and PowerVision. Past investments include athenahealth (NASDAQ: ATHN), Illumina (NASDAQ: ILMN), Sirna Therapeutics (acquired by Merck) and Xenoport (NASDAQ: XNPT). Bryan was named a Henry Crown Fellow by the Aspen Institute in 2006 and has been the highest-ranking health care investor on Forbes’ Midas List since 2008.

Immediately prior to joining Venrock, Bryan received his Ph.D. in Chemistry & Chemical Biology from Harvard University and received his B.A. from Dartmouth College. He also previously held positions in corporate finance at Kidder, Peabody & Co.

Giovanni M. Colella, MD

, Co-Founder and CEO

Giovanni M. Colella co-founded Castlight Health in 2008 with Todd Park and Bryan Roberts. Gio currently serves as chief executive officer at Castlight.

Before co-founding Castlight, Gio was founder, president, and CEO of RelayHealth (acquired by McKesson in 2006), a pioneering healthcare company that provides secure digital communications to connect doctors with their patients. Gio has also served in senior roles at Sapient and SAI, and was a consultant at the Boston Consulting Group.

Before beginning his business career, Gio practiced medicine in Manhattan and is a board certified psychiatrist. He did his fellowship in public health at Columbia University and holds an MBA from Columbia Business School.

Ann Lamont

, Managing Partner, Oak Investment Partners

Annie Lamont, Managing Partner, joined Oak Investment Partners in 1982 and served as General Partner from 1986 to 2006. Annie leads the health care and financial services technology teams at Oak.

Annie’s recent investments include Acculynk, Argus Information & Advisory Services, Benefitfocus, Castlight Health, iHealth Technologies, NetSpend, PayFlex, PharMEDium Healthcare, Radisphere National Radiology Group, TxVia and Vesta. Prior investments include athenahealth, American Esoterics, CareMedic, CLARiENT, Harbor Payments, Health Dialog, Odyssey Healthcare, Oak Tree/Oxford, Point Carbon, Psychiatric Solutions and United BioSource.

Earlier in Annie’s venture career, she developed a number of successful biopharmaceutical investments (Cephalon, ViroPharma, Esperion).

Prior to joining Oak, Annie was a research associate with Hambrecht & Quist and received her B.A. in Political Science from Stanford University. Annie currently serves on the Stanford University Board of Trustees. She has been ranked among the top 25 in Forbes Midas List of all venture investors and has also served on the Executive Board of the National Venture Capital Association.

Ed Park

, Director

Ed Park served as the Executive Vice President and Chief Operating Officer of athenahealth from July 2010 until January 1, 2017, when he stepped down from role and joined the athenahealth Board of Directors. He served as the Chief Technology Officer from March 2007 to July 2010 and served as Chief Software Architect from 1998 to March 2007. Mr. Park has served on numerous industry groups (National Alliance for Health Information Technology, Certification Commission for Health Information Technology) and corporate boards (Healthpoint Services Pvt Ltd, Kyruus). Prior to joining the Company, Mr. Park was a consultant for Viant, Inc. Mr. Park obtained a Bachelor of Arts magna cum laude from Harvard College in Computer Science.

David B. Singer

, Managing Director, MCL California, Inc., Maverick Capital

Mr. Singer is responsible for Maverick’s Private Investments globally. He joined Maverick in 2004 from Oscient Pharmaceutical Corporation, where he was Chairman of the Board. Mr. Singer is a founder and former CEO of three healthcare companies: Affymetrix, Inc., Corcept Therapeutics, Inc., and Genesoft Pharmaceuticals, Oscient’s predecessor. Mr. Singer currently serves on the boards of several private companies.

Mr. Singer received a B.A. from Yale University and an M.B.A. from Stanford University. He was a Crown Fellow of the Aspen Institute, and is currently a Sterling Fellow of Yale University, a director of College Track, and a Vice President of the San Francisco Health Commission.

Michael Eberhard

, President, Concur

Michael Eberhard joined Concur in 2003 and became President in November 2016. At Concur, he has held various roles including Executive Vice President and General Manager, Global Accounts; Executive Vice President and General Manager, Asia Pacific; and Executive Vice President, Worldwide Sales and Business Development. Prior to joining Concur, Mr. Eberhard served as Vice President, Worldwide Sales at Xign; Vice President and General Manager, Western Region for Ariba; and Vice President and General Manager, Education & Government at PeopleSoft.

Mr. Eberhard also serves on the Board of Directors of multiple private companies, including StayNTouch, a privately held hotel management technology platform company.

David Ebersman

, CEO, Lyra Health

Mr. Ebersman is founder and CEO of Lyra Health, a health care technology company focused on behavioral health. Previously, he served as Chief Financial Officer of Facebook, Inc. from 2009 through 2014. Prior to joining Facebook, Mr. Ebersman worked at Genentech, Inc. for fifteen years in various positions, including Executive Vice President and Chief Financial Officer, Senior Vice President, Product Operations, and Vice President, Product Development. Mr. Ebersman holds an A.B. in International Relations and Economics from Brown University and was selected as a Henry Crown Fellow in 2000.

Kenny Van Zant

, Director

Kenny Van Zant most recently was the Head of Business at Asana, creator of cloud-based SaaS project management tools, from March 2011 to October 2015. Prior to his role at Asana, he was the Senior Vice President, Chief Product Strategist at SolarWinds, where he led marketing and products. Mr. Van Zant has a degree in Computer Engineering from The University of Texas at Austin.

STAY IN TOUCH WITH INVESTOR RELATIONS

Contact Investor Relations

Contact Us

Email Alerts

Sign Up